
Organization
The WIN Consortium is organized in the following groups who collectively work together to achieve WIN's common goals
“The results of the SPRING trial phase I in NSCLC have been published in Cancer Medicine” WIN Consortium
WIN was formed on the premise that we can accomplish more together than each organization can achieve working alone. We aim to improve cancer patients’ survival and quality of life. View WIN's history and unique attributes:
WIN members collaboratively design and carry out global studies designed to achieve breakthroughs for patients worldwide. Our distinguished Scientific Advisory Board oversees WIN studies. Current trials include:
WIN leaders are selected for their contributions and commitment to making effective, personalized cancer medicine a reality for patients around the world. They guide WIN's strategic, operational, and scientific direction.
The WIN Consortium is organized in the following groups who collectively work together to achieve WIN's common goals
Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)
Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Chief Scientific and Operating Officer, WIN Consortium
Director, Operational Team, WIN Consortium
WIN members include 35 leading organizations representing all stakeholders in personalized cancer medicine covering 18 countries and 4 continents. Our shared vision is delivering the promise of effective, personalized cancer medicine to patients worldwide.
WIN Symposia, held annually, gathers leaders representing a breadth of stakeholders from around the world to learn, share, and collaborate. Visit http://www.winsymposium.org for registration and additional information.
WIN 2022 Symposium
October 29, 2022 - October 30, 2022ABSTRACT SUBMISSIONS FOR WIN 2022 Now Open!
Submit your abstract for the WIN Symposium 2022 dedicated to ‘Integrating Genomics and Transcriptomics to reshape Precision Oncology: a WINning Strategy’ that will take place in-person on October 29-30, 2022, Barcelona, Spain.
For further information, please visit our dedicated symposium website https://www.winsymposium.org!
WIN 2019 Symposium
June 23, 2019 - June 24, 2019The 11th edition of the WIN Symposia ‘WINnovation and Global Deployment of Precision Oncology’ took place in Paris, France on 23-24 June 2019.
Highlights and further information on the event, WIN 2019 can be found on our dedicated website at https://www.winsymposium.org/
WIN 2018 Symposium
June 25, 2018 - June 26, 2018The 10th year Anniversary edition of the WIN Symposia took place at the WIN Symposium 2018 in Paris, France on 25-26 June 2018.
The WIN Symposium Organizing Committee had chosen “Global Implementation of Precision Oncology: WINning the War against Cancer” as the theme for this celebratory event.